1. Contribution from the Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, Department of Environmental and Occupational Health, and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15238, Cellomics, Inc., Pittsburgh, Pennsylvania 15238, and Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick...